UK Awaits MHRA Medical Device Fee Consultation While Regulatory Costs Mount
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare Products Regulatory Agency's widely anticipated consultation on medical device fees is being delayed as official processes of scrutiny are still being finalized1,2. However, MHRA director of devices John Wilkinson was upbeat last week at the annual regulatory conference of the Association of British Healthcare Industries, saying: “We hope the consultation will be out next month, and when released it will be a proper exercise of six weeks or so.”